Table 3.
In vitro antifungal activity of essential oils against Candida albicans strains.
| Plant species | Source | Microorganism | MIC50% (μg/mL) | Score MIC | Ref |
|---|---|---|---|---|---|
| Achillea millefolium | Leaves | C. albicans clinical strain | 625 | ++ | [3] |
| Allium tuberosum Rottl. ex Spreng | Commercial Source | C. albicans CBS 562 | 500 | +++ | [19] |
| C. albicans clinical strain | 500 | +++ | |||
| Anethum graveolens | Seeds | C. albicans ATCC (62342) | >2001 | − | [20] |
| Candida albicans clinical strain | >2001 | − | |||
| Bursera morelensis | Leaves | C. albicans clinical strain | 125 | +++ | [21] |
| Cinnamomum burmannii | Commercial source | C. albicans ATCC 28366 | 1000 | ++ | [22] |
| Cinnamomum cassia | Bark | C. albicans ATCC 76485 | 64 | ++++ | [23] |
| C. albicans C01-C11 | 64 | ++++ | |||
| Cinnamomum zeylanicum | Commercial source | C. albicans ATCC 76845 | 312.5 | +++ | [24] |
| Cinnamomum zeylanicum | Commercial source | C. albicans ATCC 76485 | 312.5 | +++ | [25] |
| C. albicans ATCC 76645 | 312.5 | +++ | |||
| C. albicans clinical strain | 625 | ++ | |||
| Cinnamomum zeylanicum Blume | Commercial source | C. albicans ATCC 40277 | 312.5 | +++ | [14] |
| C. albicans clinical strain | 312.5 | +++ | |||
| Cinnamomum zeylanicum Blume | Commercial source | C. albicans CBS 562 | 250 | +++ | [26] |
| C. albicans ATCC 60193 | 250 | +++ | |||
| C. albicans ATCC 90029 | 125 | +++ | |||
| C. albicans LM01 | 250 | +++ | |||
| C. albicans LM03 | 250 | +++ | |||
| C. albicans LM04 | 500 | +++ | |||
| Coriandrum sativum | Commercial source | C. albicans CBS 562 | 15.0 | ++++ | [19] |
| C. albicans clinical strain 3 A5 | 31.0 | ++++ | |||
| Coriandrum sativum L. | Leaves | C. albicans CBS 562 | 15.6 | ++++ | [27] |
| Cuminum cyminum | Seeds | C. albicans ATCC62342 | >2001 | − | [20] |
| C. albicans clinical strain | >2001 | − | |||
| Curcuma longa L. | Rhizomes | C. albicans Clinical strain | 625 | ++ | [3] |
| Laurus nobilis L. | Commercial source | C. albicans ATCC 60193 | 250 | +++ | [28] |
| Melaleuca alternifólia | Commercial source | C. albicans ATCC 289065 | >2001 | − | [29] |
| C. albicans ATCC 40277 | >2001 | − | |||
| Melaleuca alternifolia | Commercial source | C. albicans ATCC 18804 | 1950 | + | [30] |
| Melaleuca alternifolia | Commercial source | C. albicans clinical strain | >2001 | − | [31] |
| Pimpinella anisum | Seeds | C. albicans ATCC 62342 | >2001 | − | [20] |
| Candida albicans clinical strain | >2001 | − | |||
| Ocotea odorifera | Commercial source | C. albicans ATCC-90028 | >2001 | − | [24] |
| C. albicans ATCC-76615 | >2001 | − | |||
| C. albicans ATCC-76645 | >2001 | − | |||
| C. albicans ATCC-76485 | >2001 | − | |||
| C. albicans clinical strain | >2001 | − | |||
| Rosmarinus officinalis | Commercial source | C. albicans, ATCC 289065 | 562,5 | ++ | [29] |
| C. albicans ATCC 40277 | <2001 | − | |||
| Rosmarinus officinalis L. | Commercial source | C. albicans ATCC-90028 | >2001 | − | [24] |
| C. albicans ATCC-76615 | >2001 | − | |||
| C. albicans ATCC-76645 | >2001 | − | |||
| C. albicans ATCC-76485 | >2001 | − | |||
| C. albicans clinical strain | >2001 | − | |||
| Santolina chamaecyparissus | Commercial source | C. albicans CBS 562 | 1000 | ++ | [19] |
| C. albicans clinical strain | >2001 | − | |||
| Satureja hortensis L. | Leaves | C. albicans Clinical strain | 200 | +++ | [32] |
nt (not tested); comparative MIC values (μg/mL): (++++) <100; (+++) 100 to 500; (++) 501 to 1000; (+) >1001 to 2000; (−) >2001.